S0502 Advanced GIST PreStudy Form NCT00324987 S0502 Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor Source Form: NCI FormBuilder:

  1. 9/19/12 9/19/12 -
  2. 8/8/14 8/8/14 - Martin Dugas
  3. 1/9/15 1/9/15 - Martin Dugas
  4. 6/12/15 6/12/15 -
Uploaded on:

June 12, 2015

To request one please log in.
License :
Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

S0502 Advanced GIST PreStudy Form NCT00324987

No Instruction available.

  1. StudyEvent: S0502 Advanced GIST PreStudy Form
    1. No Instruction available.
Eligibility Verification
Performance Status
Liver metastases (Hepatic)
Cardiovascular/ Gastrointestinal Event
Current Disease Status
Site(s) of Disease (recommend to replace SWOG term "Fill in the box for each involved site" select all that apply)
Was a complete resection done? (recommend to replace SWOG term "Was primary completely resected?")
Recurrent disease?
Tumor Grade
Distant metastases present?
Sarcoma Histologic Category
Patient History
Does patient have history of adrenal cancer (Patient History indicative of Carney's triad)
Prior Treatment Related To This Cancer
Prior Therapy Type (s select ALL that apply)
Setting of prior agent targeting VEGF, VEGFR, or PDGFR
Setting of prior imatinib (select all that apply)
Was patient restaged after initiation of imatinib therapy
Does patient have clinical evidence of progressive disease

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial